This page shows the latest Juvenescence news and features for those working in and with pharma, biotech and healthcare.
Juvenescence is backed by British billionaire Jim Mellon and recently raised $50m in a series A funding round. ... Napa Therapeutics lets Juvenescence deepen our collaboration with the Buck Institute and with Insilico Medicine.
Billionaire's belief in emerging anti-ageing therapies fuels start up. Juvenescence, a UK biotech company focused on developing anti-ageing therapies, has secured $50m in a series A financing round. ... shareholders of Juvenescence and we don’t want
A rapid round up of pharma, biotech and healthcare news
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...